Arena Pharmaceuticals Inc. (ARNA)

51.94
NASDAQ : Health Technology
Prev Close 52.33
Day Low/High 50.83 / 52.49
52 Wk Low/High 31.97 / 64.48
Avg Volume 460.00K
Exchange NASDAQ
Shares Outstanding 49.83M
Market Cap 2.61B
EPS -0.60
P/E Ratio 4.30
Div & Yield N.A. (N.A)
The Headlines Are Wrong -- This Is an Extremely Bullish Market

The Headlines Are Wrong -- This Is an Extremely Bullish Market

It is two totally different markets when you compare the small-cap action to the big-cap indices.

Small-Caps Are the Place to Be for Now

Small-Caps Are the Place to Be for Now

We are seeing a focus on finding smaller names that may offer interesting valuations and stories.

Market Bifurcation: Individual Stocks Are Acting Better Than the Indices

Market Bifurcation: Individual Stocks Are Acting Better Than the Indices

This underperformance is being caused by pockets of weakness in bigger-cap names.

Reminder: Healthy Stock Markets Decline, Too

Reminder: Healthy Stock Markets Decline, Too

The key for the overall market now is that it hold above today's early lows.

Many Names on My Radar

Many Names on My Radar

There is no question that we are becoming extended and ripe for some profit taking.

Trump's Drug Pricing Plan Makes Me Want to Play Ball With Biotech Stocks

Trump's Drug Pricing Plan Makes Me Want to Play Ball With Biotech Stocks

Sector charts should shape up as worries about prices are finally put to rest.

Having Some Good Luck With Biotech Names

Having Some Good Luck With Biotech Names

Overall it is still a positive day but the action is sloppy.

Markets Make an Art of Unpredictability

Markets Make an Art of Unpredictability

Oil isn't the only reason stocks are higher.

Buffett's Apple Move Doesn't Do Much to Shift the Negative Technical Pattern

Buffett's Apple Move Doesn't Do Much to Shift the Negative Technical Pattern

Finding good setups in individual stocks is still challenging as there simply isn't a lot of strong momentum.

Smaller Companies Are Often Some of the Best Trading Vehicles

Smaller Companies Are Often Some of the Best Trading Vehicles

The challenge of this market is that the upward moves have not been well sustained.

Walgreens, Arena Pharma, Dominion Energy: 'Mad Money' Lightning Round

Walgreens, Arena Pharma, Dominion Energy: 'Mad Money' Lightning Round

Jim Cramer focuses on Walgreens Boots Alliance, Arena Pharmaceutical, Dominion Energy, Tower Semiconductor, Idexx, LexinFintech Holdings and more.

FANG, Tariffs, Trade: Cramer's 'Mad Money' Recap (Thursday 4/26/18)

FANG, Tariffs, Trade: Cramer's 'Mad Money' Recap (Thursday 4/26/18)

It's not all about the bond market, says Jim Cramer. The central issues here are trade, tariffs and most important, the stocks themselves, like Facebook and Amazon.

ARNA June 8th Options Begin Trading

Investors in Arena Pharmaceuticals Inc saw new options become available today, for the June 8th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARNA options chain for the new June 8th contracts and identified one put and one call contract of particular interest.

3 Sectors I'm Trading Right Now as a Market Rotation Takes Hold

3 Sectors I'm Trading Right Now as a Market Rotation Takes Hold

Rotational action is the main theme Wednesday and good opportunities are out there.

ARNA May 11th Options Begin Trading

Investors in Arena Pharmaceuticals Inc saw new options begin trading today, for the May 11th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARNA options chain for the new May 11th contracts and identified one put and one call contract of particular interest.

My Biggest Concern About This Stock Market

My Biggest Concern About This Stock Market

There's a worrisome scenario that could develop this afternoon.

Here's When You Can Buy Twitter's Stock

Here's When You Can Buy Twitter's Stock

There just aren't any pockets of strong momentum right now.

Arena Pharmaceuticals Reaches Analyst Target Price

Arena Pharmaceuticals Reaches Analyst Target Price

In recent trading, shares of Arena Pharmaceuticals Inc have crossed above the average analyst 12-month target price of $36.00, changing hands for $36.21/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Revance Therapeutics Soars on Phase 3 Data -- Biotech Movers

Revance Therapeutics Soars on Phase 3 Data -- Biotech Movers

The Newark, Calif.-based firm unveiled positive top-line results from a pair of studies evaluating RT002 for the treatment of glabellar, or frown, lines.

A Stampede of Buying: Cramer's 'Mad Money' Recap (Monday 9/11/17)

A Stampede of Buying: Cramer's 'Mad Money' Recap (Monday 9/11/17)

Jim Cramer says it's a very rare moment when the absence of negatives, however fleeting or relative, creates a stampede of buying.

Allergan, USG Corp, Arena Pharmaceuticals: 'Mad Money' Lightning Round

Allergan, USG Corp, Arena Pharmaceuticals: 'Mad Money' Lightning Round

Jim Cramer is bullish on Allergan, USG Corp, and Arena Pharmaceuticals.

These Stocks Have Changed Direction

These Stocks Have Changed Direction

Finding bullish and bearish reversals in the market.

Pharma Bro Martin Shkreli Awaits Jury Decision in Fraud Case

Pharma Bro Martin Shkreli Awaits Jury Decision in Fraud Case

Former hedge funder and biotech CEO Martin Shkreli finds himself in limbo as a criminal jury now decides if allegations of fraud will put him in orange coveralls.

Arena Pharma Skyrockets on Heart Disease Data, Stock Could Still Double -Firm Says

Arena Pharma Skyrockets on Heart Disease Data, Stock Could Still Double -Firm Says

The company just beat a bench mark, previously set by Johnson & Johnson.

Xilinx, Arena Pharmaceuticals, Magellan Midstream: 'Mad Money' Lightning Round

Xilinx, Arena Pharmaceuticals, Magellan Midstream: 'Mad Money' Lightning Round

Jim Cramer is bullish on Xilinx, Arena Pharmaceuticals, Magellan Midstream, Altria and Bank of Montreal.

'I Love the Down-and-Outers': Cramer's 'Mad Money' Recap (Thursday 7/13/17)

'I Love the Down-and-Outers': Cramer's 'Mad Money' Recap (Thursday 7/13/17)

Cramer says it's the sign of a good market: Investors are finding value in the stocks that were left behind.

This $3 Biotech Stock Is Making an 11% Move Thursday

This $3 Biotech Stock Is Making an 11% Move Thursday

In focus.

Arena Pharma's Stock Could Still Double Even After Tuesday's Epic Run

Arena Pharma's Stock Could Still Double Even After Tuesday's Epic Run

Big gains could be ahead for investors willing to stick with the stock, according to one firm.

Biotech Movers: Alexion, Arena, Novavax

Biotech Movers: Alexion, Arena, Novavax

Alexion, Arena and Novavax were among the biotech stock movers ahead of the market open on Friday, July 7.

Citi Sees This Drug Maker's Stock Soaring 53% Because of What It's Working On

Citi Sees This Drug Maker's Stock Soaring 53% Because of What It's Working On

Citi initiated Arena with a 'buy' rating.

TheStreet Quant Rating: C+ (Hold)